Suppr超能文献

[放射性标记的癌胚抗原抗体在胃肠道癌患者中的定位]

[Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma].

作者信息

Ohashi A

出版信息

Nihon Geka Gakkai Zasshi. 1986 Mar;87(3):297-306.

PMID:3713682
Abstract

Present study was undertaken to investigate accumulation of radiolabeled antibody to CEA in CEA-producing tumor and possibility of radioimmunodetection of cancer with antibody. Nine patients with gastric carcinoma and seventeen colorectal carcinoma were studied. Antibody to CEA were produced in horse by immunization with CEA purified from hepatic metastasis of colorectal carcinoma. The purified antibodies were labeled with 125I or 131I. The patients who entered these studies received radioactive antibodies to CEA intravenously 24-48 hours prior to operation. Radioactivity in tumor tissues and normal mucosal tissues obtained at the operation was counted by gamma-scintillation counter. In four patients with liver metastasis from colorectal carcinoma, external photoscanning was also performed for radioimmunodetection of cancer with 131I-labeled antibody to CEA. The results were as follows. The mean ratio of 125I-uptake of cancer tissue to that of normal mucosal tissue was 3.28 +/- 1.52 (n = 26), and ratio to peripheral blood, liver, skin and fat tissue was 1.91 +/- 1.32, 2.90 +/- 1.47, 5.70 +/- 3.28 and 12.86 +/- 8.48, respectively. Tumor tissue showed the highest uptake. Accumulation of radiolabeled antibody to CEA in tumor tissue was higher in patients with relatively high serum CEA level. High level of circulating CEA did not hinder accumulation of radiolabeled antibody to CEA in tumor tissue. In two out of four patients with liver metastasis from colorectal carcinoma, the tumor location was successfully demonstrated by external photoscanning using gamma-camera. The information obtained in the present study provided possibility of direct radioimmunodetection and immunochemotherapy.

摘要

本研究旨在探讨放射性标记的癌胚抗原(CEA)抗体在产生CEA的肿瘤中的蓄积情况以及用该抗体进行癌症放射免疫检测的可能性。研究了9例胃癌患者和17例结直肠癌患者。通过用从结直肠癌肝转移灶中纯化的CEA免疫马匹,制备了CEA抗体。纯化后的抗体用125I或131I进行标记。参与这些研究的患者在手术前24 - 48小时静脉注射放射性CEA抗体。手术时获取的肿瘤组织和正常黏膜组织中的放射性通过γ闪烁计数器进行计数。对于4例结直肠癌肝转移患者,还用131I标记的CEA抗体进行了外部光扫描以进行癌症的放射免疫检测。结果如下。癌组织对125I的摄取与正常黏膜组织摄取的平均比值为3.28±1.52(n = 26),与外周血、肝脏、皮肤和脂肪组织摄取的比值分别为1.91±1.32、2.90±1.47、5.70±3.28和12.86±8.48。肿瘤组织显示出最高的摄取。血清CEA水平相对较高的患者,肿瘤组织中放射性标记的CEA抗体蓄积更高。循环CEA水平高并不妨碍放射性标记的CEA抗体在肿瘤组织中的蓄积。在4例结直肠癌肝转移患者中的2例,通过使用γ相机进行外部光扫描成功显示了肿瘤位置。本研究获得的信息为直接放射免疫检测和免疫化学疗法提供了可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验